METIMMOX
Phase 2 Completed
80 enrolled 13 charts
IROCAS
Phase 3 Completed
792 enrolled
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
NET02
Phase 2 Completed
58 enrolled
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Phase 1 Completed
829 enrolled 100 charts
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
Phase 2 Completed
44 enrolled
CanStem303C
Phase 3 Completed
1,253 enrolled 18 charts
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
Phase 2 Completed
Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Phase 2 Completed
229 enrolled 14 charts
Trybeca-1
Phase 3 Completed
512 enrolled 19 charts
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
Phase 3 Completed
499 enrolled 22 charts
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
Phase 1 Completed
122 enrolled
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
Phase 2 Completed
22 enrolled 8 charts
BEV-ONCO2012
Phase 2 Completed
60 enrolled
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
240 enrolled
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Phase 1 Completed
167 enrolled
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
Phase 1 Completed
141 enrolled
EPIC
Phase 2 Completed
110 enrolled 14 charts
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
Phase 1 Completed
36 enrolled
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Phase 2 Completed
266 enrolled 17 charts
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Phase 1 Completed
11 enrolled
Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines
Phase NA Completed
1,103 enrolled
A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer
Phase 2 Completed
109 enrolled 8 charts
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Phase 2 Completed
135 enrolled 17 charts
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Phase 1 Completed
15 enrolled
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
Phase 1 Completed
82 enrolled
DOUBLIRI
Phase 1 Completed
10 enrolled
Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
172 enrolled 13 charts
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Phase 2 Completed
20 enrolled
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
Phase 1 Completed
14 enrolled
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Phase 2 Completed
168 enrolled 16 charts
Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
Phase 1 Completed
40 enrolled
A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer
Phase 2 Completed
A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors
Phase 1 Completed
50 enrolled